PURA - VOL & PPS ALERT: 50 Day MA Breakout; PPS Up 100%; Outlook Upgrade; Accumulate @ $0.06 W/Potential to $1.00

Puration Inc. (PURA) Trading Wakes Up After 2 Year Slumber Following $3M Revenue Forecast On Sales From US Patented Marijuana Extract Process

New York, NY -- July 14, 2016 -- InvestorsHub NewsWire -- Wall Street Corner Report is featuring Puration, Inc. (PURA) as a promising yet undiscovered microcap public company in the emerging legal cannabis sector.

Wall Street Corner Report shed light on PURA’s recent awakening earlier this week following the Company’s announcement of a $3 million revenue forecast on sales from its US Patented Cannabis Extraction Process:

PURA Comes To Life With US Patent For Marijuana Extraction And $3M Forecast: Accumulate @ $0.04 With Potential To $1.00

With only 50 million shares I/O, volume in the last four trading days has been almost double the number of shares traded in the entire previous 2 years with nearly 3 times the dollar volume. With a weighted average share price of $0.057, almost double the 50 day $0.03 moving average, Wall Street Corner Report is upgrading its previous anticipated outlook from accumulation at $0.04 to $0.06.

Wall Street Corner Report anticipates PURA to continue experiencing an ‘accumulation phase’ with trading volume and pps increasing while the PPS remains under $0.10. Once the shareholder base has expanded and diversified through this accumulation phase, in conjunction with the Company’s prospects becoming more disseminated throughout the market, Wall Street Corner Report anticipates a breakout and rapid PPS increase to as high as $1.00.

PURA acquired the commercialization rights to a US Patented cannabis extraction process about a year ago in a deal with North American Cannabis Holdings, Inc. (USMJ). Now the Company is coming to market with its first extract products.

The Wall Street Corner Report considers PURA as a standout in the emerging cannabis sector. Albeit a more entrepreneurial and earlier version of GW Pharmaceuticals (GWPH), PURA is comparable to GWPH in that both are developing commercial applications of patented cannabis extracts.

GWPH has a market cap of $2B - approximately 33 times revenue. The majority of revenue is non-cash consideration while the company is still largely in a research phase. If PURA were to achieve a valuation at only 15 times its forecasted $3 million revenue, the PPS would be $0.90.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

Jack Taylor
info@wallstreetcornerreport.com